Most Read News

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Australia posted a seasonally adjusted merchandise trade surplus of A$12.444 billion in September, the Australian Bureau of Statistics. Exports jumped 7.0 percent on month to A$60.613 billion after adding 3.0 percent in the previous month. Imports picked up 0.4 percent worth A$48.169 billion after climbing 4.1 percent a month earlier.Powered by Commodity Insights

image

With effect from 01 November 2022

image

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ketorolac Tromethamine Injection USP, 15 mg/mL, 30 mg/mL, and 60 mg/2 mL (30 mg/mL) Single Dose Vials. This is the second injectable product approval from the companys General Sterile Facility (F-3) which was inspected in August, 2022Powered by Capital Market – Live News

image

This is the second injectable product approval from Company's General Sterile Facility (F-3) which was inspected in August, 2022.

image

Good quarterly performance expected for the company.

image

On 10 November 2022

image

The Board of Kinetic Engineering (KEL) on 02 November 2022 has allotted 8,79,310 equity shares at Rs. 116 per share (including premium of Rs 106 per share) on a preferential basis to its promoter group company, M/S Micro Age Instruments, (MAIPL) against an equity infusion of Rs 10.20 crore. Powered by Capital Market – Live News

image

On 10 November 2022

image

On 11 November 2022

Image
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.